SAD-Med-Soh: Social Anxiety Disorder in Medical Students in Sohag University

• Sponsor: Sohag University (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05336552
• Collaborator: (none)
• Enrollment: 350
• Location: 1
• Anticipated Duration (Months): 12.3
• Patients Per Site Per Month: 28.5

Study Details

Study Description

Brief Summary

The study will be done in Sohag University to assess the prevalence and associated factors of Social Anxiety Disorder among undergraduate medical students .

Condition or Disease	Intervention/Treatment	Phase
Social Anxiety Disorder	Other: Validated questionnaire : Social Phobia Inventory ( SPIN ) questionnaire

Detailed Description

Social anxiety disorder (SAD) is highly prevalent and it's the most common anxiety disorder among all types of anxiety disorders and the third most common psychiatric condition after major depression and alcohol dependence.

Social anxiety disorder (SAD) is characterized by persistent fear/anxiety about one or more social or performance situations in social settings.

SAD had a negative impact on learning ability, educational achievement, professional achievement, quality of life and social relationship & may lead to substance abuse and depressive disorders.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 350 participants
• Observational Model: Other
• Time Perspective: Cross-Sectional
• Official Title: Social Anxiety Disorder in Medical Students in Sohag University
• Actual Study Start Date: May 23, 2022
• Anticipated Primary Completion Date: May 1, 2023
• Anticipated Study Completion Date: Jun 1, 2023

Outcome Measures

Primary Outcome Measures

1. Social Phobia Inventory ( SPIN ) questionnaire [It will be measured after completion of the study , approximately in May 2023.]

   Social Phobia Inventory ( SPIN ) questionnaire which is consisted of 17 items. The answers of each item ranged from 0 ( Not at all ) to 4 ( Extremely ). The total score will be calculated to determine the severity of the problem as the following: - less than or equal 20 points means no disease, 21-30 means mild, 31-40 means moderate, 41-50 means severe , 51 or more means very severe.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 25 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Medical undergraduate students who are still studying for Bachelor of Medicine and Bachelor of Surgery ( M.B.B.Ch ) .

Exclusion Criteria:

• students who will refuse to participate in this study .

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Sohag university	Sohag		Egypt

Sponsors and Collaborators

• Sohag University

Investigators

• Study Director: Osama Morad, Lecturer, [e-mail]
• Study Director: Taher Abd-Elraheem-Sayed, Assistant professor, [e-mail]

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Mina Saad Louis, Sohag University, Sohag University
• ClinicalTrials.gov Identifier: NCT05336552
• Other Study ID Numbers: Soh-Med-22-04-13
• First Posted: Apr 20, 2022
• Last Update Posted: May 27, 2022
• Last Verified: May 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Anxiety Disorders; Phobia, Social

Study Results

No Results Posted as of May 27, 2022